Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | XBP1 | P17861 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 6/20 | 0.33 |
| ▸ | CA12 | O43570 | 4/20 | 0.33 |
| ▸ | CA9 | Q16790 | 4/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18034190 | 0.75 | MAPT (0.50) | SMN1; SMN2RAB9AMAPTLMNATSHR | |
| SCHEMBL1373404 | 0.74 | MAPT (0.48) | SMN1; SMN2RAB9AMAPTLMNATSHR | |
| SCHEMBL10181728 | 0.72 | CA2 (0.61) | SMN1; SMN2RAB9AMAPTLMNATSHR | |
| SCHEMBL19844938 | 0.71 | MAPT (0.46) | SMN1; SMN2RAB9AMAPTLMNATSHR | |
| SCHEMBL11332676 | 0.71 | CA2 (0.62) | SMN1; SMN2RAB9AMAPTLMNATSHR | |
| SCHEMBL11340951 | 0.71 | TSHR (0.62) | SMN1; SMN2RAB9AMAPTLMNATSHR | |
| SCHEMBL11331066 | 0.70 | CA2 (0.60) | SMN1; SMN2MAPTLMNAALDH1A1TP53 | |
| SCHEMBL11334081 | 0.70 | CA2 (0.60) | SMN1; SMN2MAPTLMNAALDH1A1TP53 | |
| SCHEMBL11326055 | 0.70 | CA2 (0.60) | SMN1; SMN2MAPTLMNAALDH1A1TP53 | |
| SCHEMBL11323074 | 0.70 | CA2 (0.60) | SMN1; SMN2MAPTLMNAALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11155568-B2 | Bioadhesives | NUTECH VENTURES (US) | 2021-10-26 | — | — | US | disclosed |
| US-20200095270-A1 | METHODS OF MAKING AND USING LIGNIN DERIVATIVES | NUTECH VENTURES | 2020-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11155568-B2 | Bioadhesives | EPCAM, VCAM1, SELP | SMN1; SMN2 4455/4885RAB9A 2402/4885MAPT 1598/4885 |
| US-20200095270-A1 | METHODS OF MAKING AND USING LIGNIN DERIVATIVES | HLCS, LOX, DCXR | SMN1; SMN2 4440/4885RAB9A 3730/4885MAPT 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.